SCHEMBL7716401

SCHEMBL7716401

C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H](C(C)(C)C=O)CC[C@@H]23)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 15/20 0.43
▸ MAPT P10636 2/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ GC P02774 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ RXRA P19793 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8526895 1.00 VDR (0.43) VDRMAPTNR1I2ABCB11GC
SCHEMBL5376543 0.93 VDR (0.41) VDRMAPTNR1I2ABCB11GC
SCHEMBL5381525 0.93 VDR (0.41) VDRMAPTNR1I2ABCB11GC
SCHEMBL8529041 0.87 VDR (0.40) VDRMAPTNR1I2ABCB11GC
SCHEMBL7715756 0.87 VDR (0.40) VDRMAPTNR1I2ABCB11GC
SCHEMBL8995653 0.86 VDR (0.42) VDRMAPTNR1I2ABCB11GC
SCHEMBL7716727 0.86 VDR (0.39) VDRMAPTNR1I2ABCB11GC
SCHEMBL7714402 0.86 VDR (0.44) VDRMAPTNR1I2ABCB11GC
SCHEMBL25310518 0.85 VDR (0.47) VDRMAPTNR1I2ABCB11GC
SCHEMBL7151478 0.85 VDR (0.47) VDRMAPTNR1I2ABCB11GC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372731-B1 TREATMENT OF CELL PROLIFERATION AND BONE DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-16 — — US disclosed
EP-0832063-B1 VITAMIN D DERIVATIVES WITH C-25 SUBSTITUENTS, PROCESS FOR THEIR PREPARATION, INTERMEDIATE PRODUCTS AND THEIR USE IN PREPARING MEDICAMENTS SCHERING AG (DE) 2000-02-23 — — EP disclosed
Send feedback